Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of aripiprazole oral solution for schizophrenia
ChiCTR2100044653Phase 4Completed
- Sponsor
- Beijing Anding Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aripiprazole in schizophrenia, sponsored by Beijing Anding Hospital. Primary endpoint: Positive and Negative Syndrome Scale. Started Dec 2020; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR2100044653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044653.